RenovoRx, Inc. has announced the appointment of Richard Stark to its Board of Directors, effective November 18, 2026. This decision increases the board size from six to seven members, a strategic move that could enhance the company's governance and direction.
Stark, who has over 30 years of experience in the medical technology industry, is expected to bring valuable insights to RenovoRx. His background includes founding and leading various medical technology companies, making him a significant addition to the board.
Background
RenovoRx, Inc. operates in the surgical and medical instruments and apparatus sector, classified under SIC code 3841. The company is listed on the Nasdaq under the ticker RNXT. As a smaller reporting company and an emerging growth entity, RenovoRx focuses on innovative solutions in the medical field.
What the Filing Says
According to the recent SEC filing (accession number 0001493152-26-053335), the board approved Stark's appointment to fill the newly created vacancy. Stark has served as a consultant to the company since December 2024, providing strategic advice and insights.
"The Board has determined that Mr. Stark qualifies as an independent director in accordance with the requirements of the Nasdaq Stock Market LLC," the filing states.
Impact
Stark's extensive experience in medical technology, including leadership roles at companies like Innoblative Designs and Sanarus Technologies, positions him to significantly influence RenovoRx's strategic initiatives. His appointment may also attract attention from investors and stakeholders within the surgical and medical instruments industry.
What's Next
The filing does not specify what happens next following Stark's appointment, but his integration into the board is likely to be closely monitored by industry analysts and investors alike.
Read Next
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction
Orchestra BioMed CFO Acquires Shares in Recent Filing
Upwork CFO Erica Gessert Reports Major Stock Transactions




